Top Markets
Coin of the day
Imunon, Inc. Imunon, Inc.

Imunon, Inc.

CLSN
株式のランク #35102
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
株価
$1.96
最終同期: 2022-09-20
時価総額
$4.46M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Imunon, Inc. (CLSN)

カテゴリー

Imunon, Inc.(CLSN)の株価履歴
終値の最高値: $2.07 (2022-09-01)

終値の最安値: $3.32K (2008-06-01)
Imunon, Inc. の株価履歴(2008 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2022 -76.70%
2021 -7.06%
2020 -56.43%
2019 -9.75%
2018 -34.36%
2017 -62.92%
2016 -73.54%
2015 -19.45%
2014 -37.80%
2013 -89.21%
2012 314.30%
2011 -19.63%
2010 -19.31%
2009 14.94%
2008 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE